RaySearch Laboratories AB (publ) announces that the Australian Bragg Centre for Proton Therapy and Research (ABCPTR) in Adelaide, Australia has placed an order for the oncology information system RayCare®*.
ABCPTR is Australia’s first proton therapy center and the first of its kind in the southern hemisphere. It is also RaySearch’s first customer in Oceania to order RayCare. Recognizing RaySearch’ global market leadership in software solutions for particle therapy, ABCPTR selected the oncology information system RayCare to ensure safe and efficient workflows. At a later stage, ABCPTR plans to place an order for RaySearch’s treatment planning system RayStation®*.
Michael Penniment, Associate Professor, medical director at ABCPTR, says: "This partnership with RaySearch marks a significant step in ABCPTR's mission to revolutionize cancer care in Australia. By combining our clinical insights with RaySearch's technology, we're confident that we can push the boundaries of what's possible in proton therapy."
Johan Löf, founder and CEO, RaySearch, says: “We are very pleased that ABCPTR has selected RayCare from RaySearch. By supporting yet another treatment machine, this also confirms our already strong position in the particle therapy industry.”
About Australian Bragg Centre for Proton Therapy and Research
The Australian Bragg Centre for Proton Therapy and Research (ABCPTR), currently under construction, will be Australia’s first proton therapy unit and the first of its kind in the southern hemisphere. The building is expected to be completed in September 2023. From then, the proton therapy machine will undergo 12-18 months of installation and testing before patient treatments begin. ABCPTR will provide proton radiation treatment to pediatric, adolescent, and adult patients with rare cancer types. The center will also be an integral part in a global network undertaking proton therapy research. Read more on theaustralianbraggcentre.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today’s oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.
* Subject to regulatory clearance in some markets.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00